Mr. Saffee will assume oversight for large-scale manufacturing in Aurangabad, India in addition to his current leadership of AMRI's large-scale manufacturing and GMP business in the U.S. in NY. He will also work with AMRI's Holywell, UK site. Mr. Saffee will work to drive synergies among the locations to improve quality, efficiency and delivery of APIs.
Prior to joining the company, Mr. Saffee led manufacturing activities for multiple U.S.-based operations for Pfizer Global Manufacturing and Pfizer Global Human Health. Prior to Pfizer’s acquisition of Parke-Davis, Mr. Saffee held roles of increasing responsibility at Parke-Davis including director of chemical manufacturing and area production manager.
"We are pleased to announce this promotion of Mr. Saffee," said Dr. Hagen. "Mr. Saffee joined AMRI in 2009 with more than 23 years of industrial and leadership experience in the chemical manufacturing of bulk API for both human and animal health. Since joining AMRI, Rick's leadership has been instrumental in many successes achieved at the Rensselaer large scale manufacturing location. We look forward to his leadership in our continued efforts to achieve closer integration among all of our manufacturing facilities."